Facetten
Zugriff
Einrichtung
Medientyp
- Text 10
Karte
Erscheinungsjahr
Autor/in
- Fiedler, Walter
- Montesinos, Pau
- Ivanov, Vladimir 5
- Kim, Inho 4
- Laribi, Kamel 4
- alle zeigen
Sprache
- Englisch 10
10 Einträge gefunden
-
Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemia
- Jonas, Brian A
- Wei, Andrew H
- Recher, Christian
- DiNardo, Courtney D
- Jang, Jun-Ho
- Pratz, Keith
- Panayiotidis, Panayiotis
-
Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy
- Wei, Andrew H
- Panayiotidis, Panayiotis
- Montesinos, Pau
- Laribi, Kamel
- Ivanov, Vladimir
- Kim, Inho
- Novak, Jan
-
An open-label, phase I/II trial to determine the maximum tolerated dose and investigate safety, pharmacokinetics and efficacy of BI 836858, an unconjugated anti-CD33 monoclonal antibody, in combination with decitabine in patients with acute myeloid leukemia
- Fiedler, Walter
- Montesinos, Pau
- Schliemann, Christoph
- Middeke, Jan
- Vasu, Sumithira
- Scholz, Christian W
- Esteve, Jordi
-
Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial
- Heuser, Michael
- Smith, B Douglas
- Fiedler, Walter
- Sekeres, Mikkael A
- Montesinos, Pau
- Leber, Brian
- Merchant, Akil
-
6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (141/150)
- Wei, Andrew H
- Panayiotidis, Panayiotis
- Montesinos, Pau
- Laribi, Kamel
- Ivanov, Vladimir
- Kim, Inho
- Novak, Jan
-
Author Correction:6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy
- Wei, Andrew H
- Panayiotidis, Panayiotis
- Montesinos, Pau
- Laribi, Kamel
- Ivanov, Vladimir
- Kim, Inho
- Novak, Jan
-
Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial
- Heuser, Michael
- Smith, B Douglas
- Fiedler, Walter
- Sekeres, Mikkael A
- Montesinos, Pau
- Leber, Brian
- Merchant, Akil
-
-
Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy
- Cortes, Jorge E
- Heidel, Florian H
- Fiedler, Walter
- Smith, B Douglas
- Robak, Tadeusz
- Montesinos, Pau
- Candoni, Anna
-
Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
- Cortes, Jorge E
- Heidel, Florian H
- Hellmann, Andrzej
- Fiedler, Walter
- Smith, B Douglas
- Robak, Tadeusz
- Montesinos, Pau